• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2017, Vol. 19 ›› Issue (5): 462-465.DOI: 10.3969/j.issn.1671-2587.2017.05.016

• Original Articles • Previous Articles     Next Articles

Application of EBV-DNA Detection to Staging of Untreated Nasopharyngeal Carcinoma

FAN Ren-zhi   

  1. Laboratory Center of Provincial Hospital of Anhui Medical University,Hefei,230001
  • Received:2017-04-02 Online:2017-10-20 Published:2017-10-26

Abstract: Objective To investigate the correlation between plasma EBV-DNA level and clinical stage of untreated nasopharyngeal carcinoma (UNPC). Methods Clinical stage of the UNPC patients was determined by tumor node metastasis (TNM),and the content of EBV DNA in 57 UNPC patients was detected by fluorescence quantitative PCR. Result EBV-DNA positive rate was not correlated with gender and age of patients,but plasma EBV-DNA concentration of stage Ⅲ patients was higher than stage Ⅳ patients (P<0.05). EBV-DNA positive rate of patients was increased with the development of T stage progress. The EBV-DNA concentration of stage T4 patients was higher than stage T2 patients (P<0.05). No significant difference of plasma EBV-DNA concentration between the stage M and stage N patients. Conclusion The level of plasma EBV-DNA concentration is positively correlated with clinical stages of nasopharyngeal carcinoma. Detection of plasma EBV-DNA by fluorescence quantitative PCR is a useful auxiliary method for UNPC diagnosis.

Key words: Real-time PCR, Nasopharyngeal carcinoma, Epstein-barr virus EBV

CLC Number: